,date,title,url
0,2004-04-19,益佰制药监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-19/600594_20040419_2.pdf
1,2004-04-19,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-19/600594_20040419_1.pdf
2,2004-04-19,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-19/600594_2004_1.pdf
3,2004-04-20,益佰制药2004年第一季度报告补充公告,/disclosure/listedinfo/announcement/c/2004-04-20/600594_20040420_1.pdf
4,2004-05-18,益佰制药2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-05-18/600594_20040518_1.pdf
5,2004-05-22,益佰制药2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-05-22/600594_20040522_1.pdf
6,2004-05-22,益佰制药2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-05-22/600594_20040522_2.pdf
7,2004-05-22,益佰制药2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-05-22/600594_20040522_3.pdf
8,2004-08-16,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-16/600594_20040816_1.pdf
9,2004-08-16,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-16/600594_2004_zzy.pdf
10,2004-08-16,益佰制药半年报,/disclosure/listedinfo/announcement/c/2004-08-16/600594_2004_z.pdf
11,2004-10-29,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-29/600594_2004_3.pdf
12,2004-11-23,益佰制药关于子公司诉讼事项的公告,/disclosure/listedinfo/announcement/c/2004-11-23/600594_20041123_1.pdf
13,2004-12-21,益佰制药关于取得2004年度广告费税前全额扣除批复的公告,/disclosure/listedinfo/announcement/c/2004-12-21/600594_20041221_1.pdf
14,2004-12-24,益佰制药关于子公司诉讼事项进展的公告,/disclosure/listedinfo/announcement/c/2004-12-24/600594_20041224_1.pdf
15,2005-01-05,益佰制药关于对外投资的公告,/disclosure/listedinfo/announcement/c/2005-01-05/600594_20050105_1.pdf
16,2005-03-31,益佰制药总经理工作细则,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_7.pdf
17,2005-03-31,益佰制药子公司管理制度,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_13.pdf
18,2005-03-31,益佰制药信息披露制度,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_11.pdf
19,2005-03-31,益佰制药投资者关系管理制度,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_10.pdf
20,2005-03-31,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2005-03-31/600594_2004_nzy.pdf
21,2005-03-31,益佰制药年报,/disclosure/listedinfo/announcement/c/2005-03-31/600594_2004_n.pdf
22,2005-03-31,益佰制药内部关联交易决策制度,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_12.pdf
23,2005-03-31,益佰制药募集资金管理使用办法,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_9.pdf
24,2005-03-31,益佰制药累积投票制实施细则,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_8.pdf
25,2005-03-31,益佰制药监事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_2.pdf
26,2005-03-31,益佰制药股东大会议事规则,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_6.pdf
27,2005-03-31,益佰制药对外担保管理制度,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_5.pdf
28,2005-03-31,益佰制药董事会专门委员会实施细则,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_3.pdf
29,2005-03-31,益佰制药董事会议事规则,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_4.pdf
30,2005-03-31,益佰制药董事会决议暨召开2004年度股东大会公告,/disclosure/listedinfo/announcement/c/2005-03-31/600594_20050331_1.pdf
31,2005-04-22,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-22/600594_20050422_1.pdf
32,2005-04-22,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-22/600594_2005_1.pdf
33,2005-05-17,益佰制药2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-05-17/600594_20050517_1.pdf
34,2005-05-21,益佰制药上市公司章程,/disclosure/listedinfo/announcement/c/2005-05-21/600594_20050521_g.pdf
35,2005-05-21,益佰制药募集资金使用管理办法,/disclosure/listedinfo/announcement/c/2005-05-21/600594_20050521_7.pdf
36,2005-05-21,益佰制药股东大会议事规则,/disclosure/listedinfo/announcement/c/2005-05-21/600594_20050521_5.pdf
37,2005-05-21,益佰制药董事会议事规则,/disclosure/listedinfo/announcement/c/2005-05-21/600594_20050521_6.pdf
38,2005-05-21,益佰制药2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-05-21/600594_20050521_1.pdf
39,2005-05-21,益佰制药2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-05-21/600594_20050521_8.pdf
40,2005-05-21,益佰制药2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-05-21/600594_20050521_4.pdf
41,2005-06-03,益佰制药2004年度利润分配及转增股本实施公告,/disclosure/listedinfo/announcement/c/2005-06-03/600594_20050603_1.pdf
42,2005-07-14,益佰制药关于退还多扣缴2004年度派息红利个人所得税的公告,/disclosure/listedinfo/announcement/c/2005-07-14/600594_20050714_1.pdf
43,2005-08-22,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-22/600594_2005_zzy.pdf
44,2005-08-22,益佰制药半年报,/disclosure/listedinfo/announcement/c/2005-08-22/600594_2005_z.pdf
45,2005-10-17,益佰制药关于召开股权分置改革相关股东会议的通知,/disclosure/listedinfo/announcement/c/2005-10-17/600594_20051017_1.pdf
46,2005-10-17,益佰制药关于进行股权分置改革网上交流会的提示性公告,/disclosure/listedinfo/announcement/c/2005-10-17/600594_20051017_2.pdf
47,2005-10-17,益佰制药股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2005-10-17/600594_20051017_5.pdf
48,2005-10-17,益佰制药股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2005-10-17/600594_20051017_4.pdf
49,2005-10-17,益佰制药股权分置改革说明书,/disclosure/listedinfo/announcement/c/2005-10-17/600594_20051017_3.pdf
50,2005-10-17,益佰制药股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2005-10-17/600594_20051017_6.pdf
51,2005-10-17,益佰制药独立董事关于股权分置改革之独立意见,/disclosure/listedinfo/announcement/c/2005-10-17/600594_20051017_7.pdf
52,2005-10-17,益佰制药董事会投票委托征集函,/disclosure/listedinfo/announcement/c/2005-10-17/600594_20051017_8.pdf
53,2005-10-26,益佰制药重大事项公告,/disclosure/listedinfo/announcement/c/2005-10-26/600594_20051026_7.pdf
54,2005-10-26,益佰制药关于股权分置改革方案沟通协商情况暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2005-10-26/600594_20051026_1.pdf
55,2005-10-26,益佰制药股权分置改革之补充保荐意见,/disclosure/listedinfo/announcement/c/2005-10-26/600594_20051026_4.pdf
56,2005-10-26,益佰制药股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2005-10-26/600594_20051026_3.pdf
57,2005-10-26,益佰制药股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2005-10-26/600594_20051026_2.pdf
58,2005-10-26,益佰制药股权分置改革的补充法律意见书,/disclosure/listedinfo/announcement/c/2005-10-26/600594_20051026_5.pdf
59,2005-10-26,益佰制药独立董事关于调整公司股权分置改革方案之独立意见,/disclosure/listedinfo/announcement/c/2005-10-26/600594_20051026_6.pdf
60,2005-10-27,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-27/600594_2005_3.pdf
61,2005-11-10,益佰制药关于召开股权分置改革相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2005-11-10/600594_20051110_1.pdf
62,2005-11-21,益佰制药关于召开股权分置改革相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2005-11-21/600594_20051121_1.pdf
63,2005-11-24,益佰制药股权分置改革相关股东会议的法律意见书,/disclosure/listedinfo/announcement/c/2005-11-24/600594_20051124_2.pdf
64,2005-11-24,益佰制药股权分置改革相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2005-11-24/600594_20051124_1.pdf
65,2005-11-29,益佰制药股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2005-11-29/600594_20051129_1.pdf
66,2005-12-21,G益佰董事会决议公告,/disclosure/listedinfo/announcement/c/2005-12-21/600594_20051221_1.pdf
67,2005-12-26,G益佰董事会决议公告,/disclosure/listedinfo/announcement/c/2005-12-26/600594_20051226_1.pdf
68,2006-01-21,G益佰董事会决议公告,/disclosure/listedinfo/announcement/c/2006-01-21/600594_20060121_1.pdf
69,2006-04-06,G益佰关于收购西藏诺迪康药业股份有限公司股份事项进展的公告,/disclosure/listedinfo/announcement/c/2006-04-06/600594_20060406_1.pdf
70,2006-04-15,G益佰年报摘要,/disclosure/listedinfo/announcement/c/2006-04-15/600594_2005_nzy.pdf
71,2006-04-15,G益佰年报,/disclosure/listedinfo/announcement/c/2006-04-15/600594_2005_n.pdf
72,2006-04-15,G益佰控股股东及其他关联方资金占用和对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2006-04-15/600594_20060415_3.pdf
73,2006-04-15,G益佰监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-15/600594_20060415_2.pdf
74,2006-04-15,G益佰董事会决议公告暨召开2005年度股东大会的公告,/disclosure/listedinfo/announcement/c/2006-04-15/600594_20060415_1.pdf
75,2006-04-25,G益佰第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-25/600594_2006_1.pdf
76,2006-05-16,G益佰股东大会议事规则（2006修订）,/disclosure/listedinfo/announcement/c/2006-05-16/600594_20060516_3.pdf
77,2006-05-16,G益佰公司章程,/disclosure/listedinfo/announcement/c/2006-05-16/600594_20060516_g.pdf
78,2006-05-16,G益佰2005年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-16/600594_20060516_2.pdf
79,2006-05-16,G益佰2005年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-05-16/600594_20060516_1.pdf
80,2006-05-17,G益佰2005年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-05-17/600594_20060517_1.pdf
81,2006-05-30,G益佰2005年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2006-05-30/600594_20060530_1.pdf
82,2006-06-02,G益佰董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-06-02/600594_20060602_1.pdf
83,2006-06-21,G益佰第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-06-21/600594_20060621_1.pdf
84,2006-06-21,G益佰2006年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-06-21/600594_20060621_2.pdf
85,2006-08-24,G益佰关于股东部分股权质押公告,/disclosure/listedinfo/announcement/c/2006-08-24/600594_20060824_1.pdf
86,2006-08-30,G益佰半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-30/600594_2006_zzy.pdf
87,2006-08-30,G益佰半年报,/disclosure/listedinfo/announcement/c/2006-08-30/600594_2006_z.pdf
88,2006-09-23,G益佰关于诉讼事项公告,/disclosure/listedinfo/announcement/c/2006-09-23/600594_20060923_1.pdf
89,2006-09-28,G益佰董事会决议公告,/disclosure/listedinfo/announcement/c/2006-09-28/600594_20060928_1.pdf
90,2006-10-10,益佰制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-10-10/600594_20061010_1.pdf
91,2006-10-21,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-21/600594_2006_3.pdf
92,2006-10-31,益佰制药第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-10-31/600594_20061031_1.pdf
93,2006-10-31,益佰制药2006年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-10-31/600594_20061031_2.pdf
94,2006-12-02,益佰制药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-12-02/600594_20061202_2.pdf
95,2006-12-02,益佰制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-12-02/600594_20061202_1.pdf
96,2006-12-16,益佰制药关于股东大会延期的公告,/disclosure/listedinfo/announcement/c/2006-12-16/600594_20061216_1.pdf
97,2006-12-21,益佰制药第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-12-21/600594_20061221_1.pdf
98,2006-12-22,益佰制药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2006-12-22/600594_20061222_1.pdf
99,2006-12-26,益佰制药公司章程（2006修订）,/disclosure/listedinfo/announcement/c/2006-12-26/600594_20061226_g.pdf
100,2006-12-26,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-12-26/600594_20061226_2.pdf
101,2006-12-26,益佰制药第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-12-26/600594_20061226_1.pdf
102,2006-12-26,益佰制药2006年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-12-26/600594_20061226_3.pdf
103,2006-12-28,益佰制药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-12-28/600594_20061228_1.pdf
104,2007-01-18,益佰制药提示性公告,/disclosure/listedinfo/announcement/c/2007-01-18/600594_20070118_1.pdf
105,2007-01-18,益佰制药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2007-01-18/600594_20070118_2.pdf
106,2007-01-23,益佰制药关于变更法人代表的公告,/disclosure/listedinfo/announcement/c/2007-01-23/600594_20070123_1.pdf
107,2007-01-31,益佰制药2006年度业绩预警公告,/disclosure/listedinfo/announcement/c/2007-01-31/600594_20070131_1.pdf
108,2007-03-22,益佰制药2006年度业绩预告更正公告,/disclosure/listedinfo/announcement/c/2007-03-22/600594_20070322_1.pdf
109,2007-04-10,益佰制药提示性公告,/disclosure/listedinfo/announcement/c/2007-04-10/600594_20070410_1.pdf
110,2007-04-10,益佰制药股东简式权益变动报告书,/disclosure/listedinfo/announcement/c/2007-04-10/600594_20070410_2.pdf
111,2007-04-12,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2007-04-12/600594_2006_nzy.pdf
112,2007-04-12,益佰制药年报,/disclosure/listedinfo/announcement/c/2007-04-12/600594_2006_n.pdf
113,2007-04-12,益佰制药控股股东及其他关联方资金占用情况的说明,/disclosure/listedinfo/announcement/c/2007-04-12/600594_20070412_3.pdf
114,2007-04-12,益佰制药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-12/600594_20070412_2.pdf
115,2007-04-12,益佰制药董事会决议公告暨召开2006年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-04-12/600594_20070412_1.pdf
116,2007-04-23,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-23/600594_20070423_1.pdf
117,2007-04-23,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-23/600594_2007_1.pdf
118,2007-04-27,益佰制药董事会决议暨召开2006年度股东大会的通知更正公告,/disclosure/listedinfo/announcement/c/2007-04-27/600594_20070427_1.pdf
119,2007-05-09,益佰制药2006年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-05-09/600594_20070509_1.pdf
120,2007-05-12,益佰制药2006年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-12/600594_20070512_1.pdf
121,2007-05-12,益佰制药2006年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-05-12/600594_20070512_2.pdf
122,2007-05-31,益佰制药重大事项公告,/disclosure/listedinfo/announcement/c/2007-05-31/600594_20070531_1.pdf
123,2007-06-02,益佰制药关于股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2007-06-02/600594_20070602_1.pdf
124,2007-06-08,益佰制药重大事项公告,/disclosure/listedinfo/announcement/c/2007-06-08/600594_20070608_1.pdf
125,2007-06-13,益佰制药重大事项公告,/disclosure/listedinfo/announcement/c/2007-06-13/600594_20070613_1.pdf
126,2007-06-27,益佰制药信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2007-06-27/600594_20070627_2.pdf
127,2007-06-27,益佰制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-06-27/600594_20070627_1.pdf
128,2007-07-07,益佰制药关于股东向股东大会提出临时议案的公告,/disclosure/listedinfo/announcement/c/2007-07-07/600594_20070707_1.pdf
129,2007-07-11,益佰制药2007年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-07-11/600594_20070711_1.pdf
130,2007-07-12,益佰制药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2007-07-12/600594_20070712_1.pdf
131,2007-07-18,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-07-18/600594_20070718_2.pdf
132,2007-07-18,益佰制药2007年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-07-18/600594_20070718_3.pdf
133,2007-07-18,益佰制药2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-07-18/600594_20070718_1.pdf
134,2007-07-25,益佰制药澄清公告,/disclosure/listedinfo/announcement/c/2007-07-25/600594_20070725_1.pdf
135,2007-07-26,益佰制药提示性公告,/disclosure/listedinfo/announcement/c/2007-07-26/600594_20070726_1.pdf
136,2007-07-26,益佰制药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2007-07-26/600594_20070726_2.pdf
137,2007-08-16,益佰制药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-16/600594_20070816_2.pdf
138,2007-08-16,益佰制药关于加强上市公司治理专项活动自查报告和整改计划,/disclosure/listedinfo/announcement/c/2007-08-16/600594_20070816_3.pdf
139,2007-08-16,益佰制药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-08-16/600594_20070816_1.pdf
140,2007-08-16,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-16/600594_2007_zzy.pdf
141,2007-08-16,益佰制药半年报,/disclosure/listedinfo/announcement/c/2007-08-16/600594_2007_z.pdf
142,2007-08-22,益佰制药2007年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-08-22/600594_20070822_1.pdf
143,2007-08-25,益佰制药关于举行“上市公司治理专项活动恳谈会” 的通知,/disclosure/listedinfo/announcement/c/2007-08-25/600594_20070825_1.pdf
144,2007-09-01,益佰制药关于朱益林先生辞去董事职务的公告,/disclosure/listedinfo/announcement/c/2007-09-01/600594_20070901_2.pdf
145,2007-09-01,益佰制药股东大会议事规则,/disclosure/listedinfo/announcement/c/2007-09-01/600594_20070901_4.pdf
146,2007-09-01,益佰制药公司章程,/disclosure/listedinfo/announcement/c/2007-09-01/600594_20070901_g.pdf
147,2007-09-01,益佰制药2007年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-09-01/600594_20070901_1.pdf
148,2007-09-01,益佰制药2007年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-09-01/600594_20070901_3.pdf
149,2007-09-11,益佰制药2007年度中期资本公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2007-09-11/600594_20070911_1.pdf
150,2007-09-29,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-09-29/600594_20070929_1.pdf
151,2007-10-29,益佰制药业绩预增公告,/disclosure/listedinfo/announcement/c/2007-10-29/600594_20071029_1.pdf
152,2007-10-29,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-29/600594_2007_3.pdf
153,2007-11-21,益佰制药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2007-11-21/600594_20071121_1.pdf
154,2007-11-29,益佰制药关于加强公司治理专项活动的整改报告,/disclosure/listedinfo/announcement/c/2007-11-29/600594_20071129_2.pdf
155,2007-11-29,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-11-29/600594_20071129_1.pdf
156,2007-12-11,益佰制药对外投资项目进展公告,/disclosure/listedinfo/announcement/c/2007-12-11/600594_20071211_1.pdf
157,2007-12-26,益佰制药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-12-26/600594_20071226_1.pdf
158,2008-02-23,益佰制药股权质押解除公告,/disclosure/listedinfo/announcement/c/2008-02-23/600594_20080223_1.pdf
159,2008-03-27,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2008-03-27/600594_2007_nzy.pdf
160,2008-03-27,益佰制药年报,/disclosure/listedinfo/announcement/c/2008-03-27/600594_2007_n.pdf
161,2008-03-27,益佰制药内部审计制度,/disclosure/listedinfo/announcement/c/2008-03-27/600594_20080327_6.pdf
162,2008-03-27,益佰制药控股股东及其他关联方资金占用情况的说明,/disclosure/listedinfo/announcement/c/2008-03-27/600594_20080327_3.pdf
163,2008-03-27,益佰制药监事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-27/600594_20080327_2.pdf
164,2008-03-27,益佰制药独立董事年度报告工作制度,/disclosure/listedinfo/announcement/c/2008-03-27/600594_20080327_4.pdf
165,2008-03-27,益佰制药董事会薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/2008-03-27/600594_20080327_7.pdf
166,2008-03-27,益佰制药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-27/600594_20080327_1.pdf
167,2008-03-27,益佰制药董事、监事及高级管理人员所持公司股份及其变动管理办法,/disclosure/listedinfo/announcement/c/2008-03-27/600594_20080327_5.pdf
168,2008-04-23,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-23/600594_2008_1.pdf
169,2008-05-07,益佰制药关于召开2007年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-05-07/600594_20080507_1.pdf
170,2008-05-07,益佰制药2007年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-05-07/600594_20080507_2.pdf
171,2008-05-10,益佰制药关于2007年年度股东大会增加临时提案的补充通知,/disclosure/listedinfo/announcement/c/2008-05-10/600594_20080510_1.pdf
172,2008-05-10,益佰制药2007年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-05-10/600594_20080510_2.pdf
173,2008-05-28,益佰制药2007年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-05-28/600594_20080528_1.pdf
174,2008-05-28,益佰制药2007年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-05-28/600594_20080528_2.pdf
175,2008-06-12,益佰制药关于股权分置改革方案追送对价安排实施的公告,/disclosure/listedinfo/announcement/c/2008-06-12/600594_20080612_1.pdf
176,2008-06-16,益佰制药关于实施股权分置改革追送股份的提示性公告,/disclosure/listedinfo/announcement/c/2008-06-16/600594_20080616_1.pdf
177,2008-06-27,益佰制药2007年利润分配实施公告,/disclosure/listedinfo/announcement/c/2008-06-27/600594_20080627_1.pdf
178,2008-07-23,益佰制药关于更换股权分置改革保荐人的公告,/disclosure/listedinfo/announcement/c/2008-07-23/600594_20080723_1.pdf
179,2008-07-26,益佰制药关于加强公司治理专项活动整改情况的说明,/disclosure/listedinfo/announcement/c/2008-07-26/600594_20080726_2.pdf
180,2008-07-26,益佰制药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-07-26/600594_20080726_1.pdf
181,2008-08-25,益佰制药第三届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2008-08-25/600594_20080825_1.pdf
182,2008-08-25,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-25/600594_2008_zzy.pdf
183,2008-08-25,益佰制药半年报,/disclosure/listedinfo/announcement/c/2008-08-25/600594_2008_z.pdf
184,2008-09-19,益佰制药关于股票交易异常波动的公告,/disclosure/listedinfo/announcement/c/2008-09-19/600594_20080919_1.pdf
185,2008-10-29,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-29/600594_2008_3.pdf
186,2008-11-29,益佰制药关于召开2008年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-11-29/600594_20081129_1.pdf
187,2008-11-29,益佰制药2008年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-11-29/600594_20081129_2.pdf
188,2008-12-03,益佰制药有限售条件的流通股上市流通的公告,/disclosure/listedinfo/announcement/c/2008-12-03/600594_20081203_1.pdf
189,2008-12-13,益佰制药股东减持公告,/disclosure/listedinfo/announcement/c/2008-12-13/600594_20081213_1.pdf
190,2008-12-16,益佰制药关联交易决策制度,/disclosure/listedinfo/announcement/c/2008-12-16/600594_20081216_3.pdf
191,2008-12-16,益佰制药防范控股股东及关联方占用公司资金专项制度,/disclosure/listedinfo/announcement/c/2008-12-16/600594_20081216_4.pdf
192,2008-12-16,益佰制药2008年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-12-16/600594_20081216_1.pdf
193,2008-12-16,益佰制药2008年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-12-16/600594_20081216_2.pdf
194,2008-12-24,益佰制药股东减持提示性公告,/disclosure/listedinfo/announcement/c/2008-12-24/600594_20081224_1.pdf
195,2009-01-23,益佰制药关联交易公告,/disclosure/listedinfo/announcement/c/2009-01-23/600594_20090123_2.pdf
196,2009-01-23,益佰制药第三届董事会临时会议决议公告暨召开公司2009年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-01-23/600594_20090123_1.pdf
197,2009-02-05,益佰制药2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-02-05/600594_20090205_1.pdf
198,2009-02-13,益佰制药股东持有股份变动公告,/disclosure/listedinfo/announcement/c/2009-02-13/600594_20090213_1.pdf
199,2009-02-17,益佰制药关于叶湘武先生辞去董事职务的公告,/disclosure/listedinfo/announcement/c/2009-02-17/600594_20090217_2.pdf
200,2009-02-17,益佰制药2009年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-02-17/600594_20090217_1.pdf
201,2009-02-17,益佰制药2009年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-02-17/600594_20090217_3.pdf
202,2009-03-04,益佰制药关于被认定为高新技术企业公告,/disclosure/listedinfo/announcement/c/2009-03-04/600594_20090304_1.pdf
203,2009-03-14,益佰制药关于简卫光先生辞去董事职务的公告,/disclosure/listedinfo/announcement/c/2009-03-14/600594_20090314_1.pdf
204,2009-03-25,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2009-03-25/600594_2008_nzy.pdf
205,2009-03-25,益佰制药年报,/disclosure/listedinfo/announcement/c/2009-03-25/600594_2008_n.pdf
206,2009-03-25,益佰制药控股股东及其他关联方资金占用情况的说明,/disclosure/listedinfo/announcement/c/2009-03-25/600594_20090325_3.pdf
207,2009-03-25,益佰制药董事会审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2009-03-25/600594_20090325_4.pdf
208,2009-03-25,益佰制药第三届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-25/600594_20090325_2.pdf
209,2009-03-25,益佰制药第三届董事会第十四次会议决议公告暨召开公司2008年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-03-25/600594_20090325_1.pdf
210,2009-04-03,益佰制药2008年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-04-03/600594_20090403_1.pdf
211,2009-04-16,益佰制药公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-04-16/600594_20090416_g.pdf
212,2009-04-16,益佰制药第三届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-16/600594_20090416_2.pdf
213,2009-04-16,益佰制药2008年年度股东大会会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-16/600594_20090416_1.pdf
214,2009-04-16,益佰制药2008年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-04-16/600594_20090416_3.pdf
215,2009-04-24,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-24/600594_2009_1.pdf
216,2009-08-20,益佰制药第三届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2009-08-20/600594_20090820_1.pdf
217,2009-08-20,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-20/600594_2009_zzy.pdf
218,2009-08-20,益佰制药半年报,/disclosure/listedinfo/announcement/c/2009-08-20/600594_2009_z.pdf
219,2009-10-22,益佰制药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2009-10-22/600594_20091022_2.pdf
220,2009-10-22,益佰制药股东减持提示性公告,/disclosure/listedinfo/announcement/c/2009-10-22/600594_20091022_1.pdf
221,2009-10-29,益佰制药股东减持公告,/disclosure/listedinfo/announcement/c/2009-10-29/600594_20091029_1.pdf
222,2009-10-29,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-29/600594_2009_3.pdf
223,2009-10-31,益佰制药关联交易进展公告,/disclosure/listedinfo/announcement/c/2009-10-31/600594_20091031_2.pdf
224,2009-10-31,益佰制药第三季度季报（修订版）,/disclosure/listedinfo/announcement/c/2009-10-31/600594_2009_3.pdf
225,2009-10-31,益佰制药补充更正公告,/disclosure/listedinfo/announcement/c/2009-10-31/600594_20091031_1.pdf
226,2009-11-04,益佰制药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2009-11-04/600594_20091104_2.pdf
227,2009-11-04,益佰制药股东减持提示性公告,/disclosure/listedinfo/announcement/c/2009-11-04/600594_20091104_1.pdf
228,2009-12-05,益佰制药关于公司部分产品及代理产品进入《国家基本医疗保险、工伤保险和生育保险药品目录》（2009年版）公告,/disclosure/listedinfo/announcement/c/2009-12-05/600594_20091205_1.pdf
229,2010-02-06,益佰制药关于王云杰先生辞去董事职务的公告,/disclosure/listedinfo/announcement/c/2010-02-06/600594_20100206_4.pdf
230,2010-02-06,益佰制药关联交易公告,/disclosure/listedinfo/announcement/c/2010-02-06/600594_20100206_3.pdf
231,2010-02-06,益佰制药第三届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-02-06/600594_20100206_2.pdf
232,2010-02-06,益佰制药第三届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2010-02-06/600594_20100206_1.pdf
233,2010-02-11,益佰制药召开2010年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-02-11/600594_20100211_1.pdf
234,2010-02-27,益佰制药2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-02-27/600594_20100227_1.pdf
235,2010-03-06,益佰制药关于职工监事选举结果的公告,/disclosure/listedinfo/announcement/c/2010-03-06/600594_20100306_4.pdf
236,2010-03-06,益佰制药公司章程（2010修订）,/disclosure/listedinfo/announcement/c/2010-03-06/600594_20100306_g.pdf
237,2010-03-06,益佰制药第四届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-06/600594_20100306_3.pdf
238,2010-03-06,益佰制药第四届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-06/600594_20100306_2.pdf
239,2010-03-06,益佰制药2010年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-03-06/600594_20100306_1.pdf
240,2010-03-06,益佰制药2010年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2010-03-06/600594_20100306_5.pdf
241,2010-04-02,益佰制药重大事项内部报告制度,/disclosure/listedinfo/announcement/c/2010-04-02/600594_20100402_4.pdf
242,2010-04-02,益佰制药外部信息使用人管理制度,/disclosure/listedinfo/announcement/c/2010-04-02/600594_20100402_5.pdf
243,2010-04-02,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2010-04-02/600594_2009_nzy.pdf
244,2010-04-02,益佰制药年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-04-02/600594_20100402_7.pdf
245,2010-04-02,益佰制药年报,/disclosure/listedinfo/announcement/c/2010-04-02/600594_2009_n.pdf
246,2010-04-02,益佰制药内幕信息知情人登记管理制度,/disclosure/listedinfo/announcement/c/2010-04-02/600594_20100402_6.pdf
247,2010-04-02,益佰制药控股股东及其他关联方资金占用情况的说明,/disclosure/listedinfo/announcement/c/2010-04-02/600594_20100402_3.pdf
248,2010-04-02,益佰制药第四届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-02/600594_20100402_2.pdf
249,2010-04-02,益佰制药第四届董事会第二次会议决议公告暨召开2009年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-04-02/600594_20100402_1.pdf
250,2010-04-20,益佰制药2009年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-20/600594_20100420_1.pdf
251,2010-04-24,益佰制药第四届董事会2010年第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-24/600594_20100424_1.pdf
252,2010-04-24,益佰制药承债式收购资产公告,/disclosure/listedinfo/announcement/c/2010-04-24/600594_20100424_2.pdf
253,2010-04-27,益佰制药2009年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-04-27/600594_20100427_1.pdf
254,2010-04-27,益佰制药2009年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2010-04-27/600594_20100427_2.pdf
255,2010-04-28,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-28/600594_2010_1.pdf
256,2010-05-15,益佰制药关于举行2009年年度报告网上说明会的公告,/disclosure/listedinfo/announcement/c/2010-05-15/600594_20100515_1.pdf
257,2010-06-10,益佰制药2009年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2010-06-10/600594_20100610_1.pdf
258,2010-06-22,益佰制药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2010-06-22/600594_20100622_1.pdf
259,2010-08-24,益佰制药第四届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-24/600594_20100824_3.pdf
260,2010-08-24,益佰制药第四届董事会第四次会议决议公告暨召开2010年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-08-24/600594_20100824_1.pdf
261,2010-08-24,益佰制药出售贵州黔德投资股份有限公司100％股权公告,/disclosure/listedinfo/announcement/c/2010-08-24/600594_20100824_2.pdf
262,2010-08-24,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-24/600594_2010_zzy.pdf
263,2010-08-24,益佰制药半年报,/disclosure/listedinfo/announcement/c/2010-08-24/600594_2010_z.pdf
264,2010-09-07,益佰制药2010年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-09-07/600594_20100907_1.pdf
265,2010-09-17,益佰制药公司章程（2010修订）,/disclosure/listedinfo/announcement/c/2010-09-17/600594_20100917_g.pdf
266,2010-09-17,益佰制药2010年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-09-17/600594_20100917_1.pdf
267,2010-09-17,益佰制药2010年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2010-09-17/600594_20100917_2.pdf
268,2010-10-11,益佰制药2010年度中期利润分配实施公告,/disclosure/listedinfo/announcement/c/2010-10-11/600594_20101011_1.pdf
269,2010-10-28,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-28/600594_2010_3.pdf
270,2010-12-21,益佰制药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2010-12-21/600594_20101221_2.pdf
271,2010-12-21,益佰制药关于股东减持提示性公告,/disclosure/listedinfo/announcement/c/2010-12-21/600594_20101221_1.pdf
272,2010-12-29,益佰制药关于张圣贵先生辞去监事会召集人及监事职务的公告,/disclosure/listedinfo/announcement/c/2010-12-29/600594_20101229_1.pdf
273,2011-01-06,益佰制药2010年度业绩预增公告,/disclosure/listedinfo/announcement/c/2011-01-06/600594_20110106_1.pdf
274,2011-01-24,益佰制药关于岳巍先生辞去董事及常务副总经理职务的公告,/disclosure/listedinfo/announcement/c/2011-01-24/600594_20110124_1.pdf
275,2011-02-01,益佰制药召开2011年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-02-01/600594_20110201_2.pdf
276,2011-02-01,益佰制药第四届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2011-02-01/600594_20110201_3.pdf
277,2011-02-01,益佰制药第四届董事会2011年第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2011-02-01/600594_20110201_1.pdf
278,2011-02-11,益佰制药2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-02-11/600594_20110211_1.pdf
279,2011-02-22,益佰制药第四届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2011-02-22/600594_20110222_3.pdf
280,2011-02-22,益佰制药第四届董事会2011年第二次临时会议公告,/disclosure/listedinfo/announcement/c/2011-02-22/600594_20110222_2.pdf
281,2011-02-22,益佰制药2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-02-22/600594_20110222_1.pdf
282,2011-02-22,益佰制药2011年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2011-02-22/600594_20110222_4.pdf
283,2011-04-25,益佰制药上市公司报告期控股股东及其他关联方资金占用情况表的说明,/disclosure/listedinfo/announcement/c/2011-04-25/600594_20110425_4.pdf
284,2011-04-25,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2011-04-25/600594_2010_nzy.pdf
285,2011-04-25,益佰制药年报,/disclosure/listedinfo/announcement/c/2011-04-25/600594_2010_n.pdf
286,2011-04-25,益佰制药关于召开2010年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-04-25/600594_20110425_3.pdf
287,2011-04-25,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-25/600594_2011_1.pdf
288,2011-04-25,益佰制药第四届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-25/600594_20110425_2.pdf
289,2011-04-25,益佰制药第四届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-25/600594_20110425_1.pdf
290,2011-05-07,益佰制药2010年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-05-07/600594_20110507_1.pdf
291,2011-05-18,益佰制药2010年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-05-18/600594_20110518_1.pdf
292,2011-05-18,益佰制药2010年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2011-05-18/600594_20110518_2.pdf
293,2011-05-26,益佰制药关于股东股权质押公告,/disclosure/listedinfo/announcement/c/2011-05-26/600594_20110526_1.pdf
294,2011-06-02,益佰制药关于股东股权质押公告,/disclosure/listedinfo/announcement/c/2011-06-02/600594_20110602_1.pdf
295,2011-07-30,益佰制药投资者关系管理制度,/disclosure/listedinfo/announcement/c/2011-07-30/600594_20110730_5.pdf
296,2011-07-30,益佰制药接待和推广制度,/disclosure/listedinfo/announcement/c/2011-07-30/600594_20110730_6.pdf
297,2011-07-30,益佰制药第四届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2011-07-30/600594_20110730_2.pdf
298,2011-07-30,益佰制药第四届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2011-07-30/600594_20110730_1.pdf
299,2011-07-30,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2011-07-30/600594_2011_zzy.pdf
300,2011-07-30,益佰制药半年报,/disclosure/listedinfo/announcement/c/2011-07-30/600594_2011_z.pdf
301,2011-07-30,益佰制药A股限制性股票激励计划（摘要）,/disclosure/listedinfo/announcement/c/2011-07-30/600594_20110730_4.pdf
302,2011-07-30,益佰制药A股限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2011-07-30/600594_20110730_3.pdf
303,2011-10-22,益佰制药第四届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2011-10-22/600594_20111022_1.pdf
304,2011-10-22,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-22/600594_2011_3.pdf
305,2011-12-15,益佰制药第四届董事会2011年第三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2011-12-15/600594_20111215_1.pdf
306,2011-12-29,益佰制药内部控制制度,/disclosure/listedinfo/announcement/c/2011-12-29/600594_20111229_7.pdf
307,2011-12-29,益佰制药内部控制评价办法,/disclosure/listedinfo/announcement/c/2011-12-29/600594_20111229_6.pdf
308,2011-12-29,益佰制药关于召开2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-12-29/600594_20111229_3.pdf
309,2011-12-29,益佰制药第四届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2011-12-29/600594_20111229_2.pdf
310,2011-12-29,益佰制药第四届董事会2011年第四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2011-12-29/600594_20111229_1.pdf
311,2011-12-29,益佰制药A股限制性股票激励计划（摘要）,/disclosure/listedinfo/announcement/c/2011-12-29/600594_20111229_5.pdf
312,2011-12-29,益佰制药A股限制性股票激励计划（草案修订稿）,/disclosure/listedinfo/announcement/c/2011-12-29/600594_20111229_4.pdf
313,2012-01-07,益佰制药2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-01-07/600594_20120107_1.pdf
314,2012-01-11,益佰制药关于召开2012年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2012-01-11/600594_20120111_1.pdf
315,2012-01-17,益佰制药第四届董事会2012年第一次临时会议决议暨限制性股票激励计划授予相关事项的公告,/disclosure/listedinfo/announcement/c/2012-01-17/600594_20120117_2.pdf
316,2012-01-17,益佰制药2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-01-17/600594_20120117_1.pdf
317,2012-01-17,益佰制药2012年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2012-01-17/600594_20120117_3.pdf
318,2012-02-10,益佰制药第四届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2012-02-10/600594_20120210_2.pdf
319,2012-02-10,益佰制药第四届董事会2012年第二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2012-02-10/600594_20120210_1.pdf
320,2012-02-18,益佰制药A股限制性股票授予完成公告,/disclosure/listedinfo/announcement/c/2012-02-18/600594_20120218_1.pdf
321,2012-03-02,益佰制药公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-03-02/600594_20120302_g.pdf
322,2012-03-02,益佰制药第四届董事会2012年第三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-02/600594_20120302_1.pdf
323,2012-03-29,益佰制药上市公司报告期控股股东及其他关联方资金占用情况表的说明,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_6.pdf
324,2012-03-29,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2012-03-29/600594_2011_nzy.pdf
325,2012-03-29,益佰制药年报,/disclosure/listedinfo/announcement/c/2012-03-29/600594_2011_n.pdf
326,2012-03-29,益佰制药内部控制审核报告,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_8.pdf
327,2012-03-29,益佰制药关于召开2011年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_3.pdf
328,2012-03-29,益佰制药关于GMP改造一期项目投资公告,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_4.pdf
329,2012-03-29,益佰制药关于2012年度日常关联交易的公告,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_5.pdf
330,2012-03-29,益佰制药第四届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_2.pdf
331,2012-03-29,益佰制药第四届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_1.pdf
332,2012-03-29,益佰制药2011年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_10.pdf
333,2012-03-29,益佰制药2011年度净利润的鉴证报告,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_9.pdf
334,2012-03-29,益佰制药2011年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2012-03-29/600594_20120329_7.pdf
335,2012-04-07,益佰制药2011年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-04-07/600594_20120407_1.pdf
336,2012-04-19,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-19/600594_2012_1.pdf
337,2012-04-19,益佰制药第四届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-19/600594_20120419_2.pdf
338,2012-04-19,益佰制药2012年度内部控制规范实施工作方案（修正稿）,/disclosure/listedinfo/announcement/c/2012-04-19/600594_20120419_4a.pdf
339,2012-04-19,益佰制药2012年度内部控制规范实施工作方案,/disclosure/listedinfo/announcement/c/2012-04-19/600594_20120419_4.pdf
340,2012-04-19,益佰制药2011年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-04-19/600594_20120419_1.pdf
341,2012-04-19,益佰制药2011年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2012-04-19/600594_20120419_3.pdf
342,2012-05-16,益佰制药2011年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2012-05-16/600594_20120516_1.pdf
343,2012-06-12,益佰制药关于收购爱德药业（北京）有限公司80%股权的公告,/disclosure/listedinfo/announcement/c/2012-06-12/600594_20120612_2.pdf
344,2012-06-12,益佰制药第四届董事会2012年第四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2012-06-12/600594_20120612_1.pdf
345,2012-06-21,益佰制药2011年年度报告网上集体说明会公告,/disclosure/listedinfo/announcement/c/2012-06-21/600594_20120621_1.pdf
346,2012-07-03,益佰制药关于收购爱德药业（北京）有限公司80%股权的公告（修订版）,/disclosure/listedinfo/announcement/c/2012-07-03/600594_20120703_2.pdf
347,2012-07-03,益佰制药关于收购爱德药业（北京）有限公司80%股权的更正公告,/disclosure/listedinfo/announcement/c/2012-07-03/600594_20120703_1.pdf
348,2012-08-22,益佰制药关于回购注销部分已不符合激励条件的原激励对象已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2012-08-22/600594_20120822_3.pdf
349,2012-08-22,益佰制药关于回购注销部分股权激励股份减少注册资本的债权人公告,/disclosure/listedinfo/announcement/c/2012-08-22/600594_20120822_4.pdf
350,2012-08-22,益佰制药第四届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-22/600594_20120822_2.pdf
351,2012-08-22,益佰制药第四届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-22/600594_20120822_1.pdf
352,2012-08-22,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-22/600594_2012_zzy.pdf
353,2012-08-22,益佰制药半年报,/disclosure/listedinfo/announcement/c/2012-08-22/600594_2012_z.pdf
354,2012-10-15,益佰制药关于部分不符合激励条件的限制性股票回购注销完成公告,/disclosure/listedinfo/announcement/c/2012-10-15/600594_20121015_1.pdf
355,2012-10-26,益佰制药关于召开2012年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-10-26/600594_20121026_2.pdf
356,2012-10-26,益佰制药第四届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-26/600594_20121026_1.pdf
357,2012-10-26,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-26/600594_2012_3.pdf
358,2012-11-06,益佰制药2012年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-11-06/600594_20121106_1.pdf
359,2012-11-16,益佰制药公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-11-16/600594_20121116_g.pdf
360,2012-11-16,益佰制药2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-11-16/600594_20121116_1.pdf
361,2012-11-16,益佰制药2012年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2012-11-16/600594_20121116_2.pdf
362,2013-01-23,益佰制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2013-01-22/600594_20130123_5.pdf
363,2013-01-23,益佰制药关于回购注销部分已不符合激励条件的原激励对象已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2013-01-22/600594_20130123_2.pdf
364,2013-01-23,益佰制药关于回购注销部分股权激励股份减少注册资本的债权人公告,/disclosure/listedinfo/announcement/c/2013-01-22/600594_20130123_3.pdf
365,2013-01-23,益佰制药关于公司限制性股票第一个解锁期符合解锁条件的公告,/disclosure/listedinfo/announcement/c/2013-01-22/600594_20130123_4.pdf
366,2013-01-23,益佰制药公司章程（2013修订）,/disclosure/listedinfo/announcement/c/2013-01-22/600594_20130123_g.pdf
367,2013-01-23,益佰制药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2013-01-22/600594_20130123_7.pdf
368,2013-01-23,益佰制药第四届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-01-22/600594_20130123_6.pdf
369,2013-01-23,益佰制药第四届董事会2013年第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-01-22/600594_20130123_1.pdf
370,2013-01-30,益佰制药重大事项停牌公告,/disclosure/listedinfo/announcement/c/2013-01-29/600594_20130130_1.pdf
371,2013-02-02,益佰制药未来三年股东回报规划(2013-2015年度),/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_7.pdf
372,2013-02-02,益佰制药募集资金管理办法,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_8.pdf
373,2013-02-02,益佰制药关于关联方认购非公开发行A股股票涉及的关联交易公告,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_2.pdf
374,2013-02-02,益佰制药股票复牌提示性公告,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_4.pdf
375,2013-02-02,益佰制药非公开发行股票募集资金运用的可行性分析报告,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_6.pdf
376,2013-02-02,益佰制药非公开发行A股股票预案,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_5.pdf
377,2013-02-02,益佰制药独立董事事前认可意见,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_9.pdf
378,2013-02-02,益佰制药独立董事独立意见,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_10.pdf
379,2013-02-02,益佰制药第四届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_3.pdf
380,2013-02-02,益佰制药第四届董事会2013年第二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-02-01/600594_20130202_1.pdf
381,2013-03-12,益佰制药前次募集资金使用情况专项报告,/disclosure/listedinfo/announcement/c/2013-03-11/600594_20130312_5.pdf
382,2013-03-12,益佰制药关于召开2013年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-03-11/600594_20130312_4.pdf
383,2013-03-12,益佰制药关于前次募集资金使用情况说明,/disclosure/listedinfo/announcement/c/2013-03-11/600594_20130312_3.pdf
384,2013-03-12,益佰制药第四届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-11/600594_20130312_2.pdf
385,2013-03-12,益佰制药第四届董事会2013年第三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-11/600594_20130312_1.pdf
386,2013-03-16,益佰制药2013年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-03-15/600594_20130316_1.pdf
387,2013-03-19,益佰制药关于部分不符合激励条件的限制性股票回购注销完成公告,/disclosure/listedinfo/announcement/c/2013-03-18/600594_20130319_1.pdf
388,2013-03-21,益佰制药关于召开2013年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2013-03-20/600594_20130321_2.pdf
389,2013-03-21,益佰制药关于第四届董事会和监事会延期换届的公告,/disclosure/listedinfo/announcement/c/2013-03-20/600594_20130321_1.pdf
390,2013-03-23,益佰制药关于签订股权转让意向书的公告,/disclosure/listedinfo/announcement/c/2013-03-22/600594_20130323_1.pdf
391,2013-03-27,益佰制药审计报告,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_16.pdf
392,2013-03-27,益佰制药上市公司报告期控股股东及其他关联方资金占用情况表的说明,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_15.pdf
393,2013-03-27,益佰制药上市公司报告期控股股东及其他关联方资金占用情况表,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_9.pdf
394,2013-03-27,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2013-03-26/600594_2012_nzy.pdf
395,2013-03-27,益佰制药年报,/disclosure/listedinfo/announcement/c/2013-03-26/600594_2012_n.pdf
396,2013-03-27,益佰制药内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_12.pdf
397,2013-03-27,益佰制药监事会对有关事项的审核意见,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_8.pdf
398,2013-03-27,益佰制药关于召开2012年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_5.pdf
399,2013-03-27,益佰制药关于2013年度日常关联交易的公告,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_4.pdf
400,2013-03-27,益佰制药独立董事对公司2012年年度报告相关事项的独立意见,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_7.pdf
401,2013-03-27,益佰制药独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_13.pdf
402,2013-03-27,益佰制药第四届监事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_3.pdf
403,2013-03-27,益佰制药第四届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_2.pdf
404,2013-03-27,益佰制药2012年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_11.pdf
405,2013-03-27,益佰制药2012年度净利润的鉴证报告,/disclosure/listedinfo/announcement/c/2013-03-26/600594_20130327_14.pdf
406,2013-03-28,益佰制药2013年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-03-27/600594_20130328_2.pdf
407,2013-03-28,益佰制药2013年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2013-03-27/600594_20130328_3.pdf
408,2013-04-09,益佰制药关于召开2012年度现金分红说明会的通知,/disclosure/listedinfo/announcement/c/2013-04-08/600594_20130409_1.pdf
409,2013-04-12,益佰制药2012年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-04-11/600594_20130412_1.pdf
410,2013-04-19,益佰制药关于召开2012年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2013-04-18/600594_20130419_1.pdf
411,2013-04-23,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-22/600594_2013_1.pdf
412,2013-04-23,益佰制药2012年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-04-22/600594_20130423_3.pdf
413,2013-04-23,益佰制药2012年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2013-04-22/600594_20130423_5.pdf
414,2013-05-15,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2013-05-14/600594_20130515_2.pdf
415,2013-05-15,益佰制药关于股东股权质押公告,/disclosure/listedinfo/announcement/c/2013-05-14/600594_20130515_1.pdf
416,2013-05-16,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2013-05-15/600594_20130516_1.pdf
417,2013-06-04,益佰制药2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-06-03/600594_20130604_1.pdf
418,2013-06-08,益佰制药关于召开2013年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-06-07/600594_20130608_3.pdf
419,2013-06-08,益佰制药关于董事会换届选举的独立意见,/disclosure/listedinfo/announcement/c/2013-06-07/600594_20130608_4.pdf
420,2013-06-08,益佰制药第四届监事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-07/600594_20130608_2.pdf
421,2013-06-08,益佰制药第四届董事会2013年第四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-07/600594_20130608_1.pdf
422,2013-06-15,益佰制药关于收购百祥制药100%股权的公告,/disclosure/listedinfo/announcement/c/2013-06-14/600594_20130615_2.pdf
423,2013-06-15,益佰制药独立董事关于评估机构专业能力、独立性的独立意见,/disclosure/listedinfo/announcement/c/2013-06-14/600594_20130615_3.pdf
424,2013-06-15,益佰制药第四届董事会2013年第五次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-14/600594_20130615_1.pdf
425,2013-06-15,益佰制药：贵州苗医药实业有限公司拟收购股权所涉及的贵州百祥制药有限责任公司股东全部权益价值评估报告,/disclosure/listedinfo/announcement/c/2013-06-14/600594_20130615_4.pdf
426,2013-06-15,益佰制药：贵州百祥制药有限责任公司审计报告,/disclosure/listedinfo/announcement/c/2013-06-14/600594_20130615_5.pdf
427,2013-06-19,益佰制药关于职工监事选举结果的公告,/disclosure/listedinfo/announcement/c/2013-06-18/600594_20130619_1.pdf
428,2013-06-19,益佰制药2013年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-06-18/600594_20130619_2.pdf
429,2013-06-27,益佰制药独立董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2013-06-26/600594_20130627_5.pdf
430,2013-06-27,益佰制药第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-26/600594_20130627_3.pdf
431,2013-06-27,益佰制药第五届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-26/600594_20130627_2.pdf
432,2013-06-27,益佰制药2013年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-06-26/600594_20130627_1.pdf
433,2013-06-27,益佰制药2013年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2013-06-26/600594_20130627_4.pdf
434,2013-08-13,益佰制药关于收购百祥制药的进展公告,/disclosure/listedinfo/announcement/c/2013-08-12/600594_20130813_1.pdf
435,2013-08-13,益佰制药：贵州百祥制药有限责任公司盈利预测审核报告,/disclosure/listedinfo/announcement/c/2013-08-12/600594_20130813_3.pdf
436,2013-08-13,益佰制药：贵州百祥制药有限责任公司盈利预测报告,/disclosure/listedinfo/announcement/c/2013-08-12/600594_20130813_2.pdf
437,2013-08-19,益佰制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2013-08-18/600594_20130819_5.pdf
438,2013-08-19,益佰制药关于回购注销部分已不符合激励条件的原激励对象已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2013-08-18/600594_20130819_3.pdf
439,2013-08-19,益佰制药关于回购注销部分股权激励股份减少注册资本的债权人公告,/disclosure/listedinfo/announcement/c/2013-08-18/600594_20130819_4.pdf
440,2013-08-19,益佰制药公司章程（2013年第二次修订）,/disclosure/listedinfo/announcement/c/2013-08-18/600594_20130819_7.pdf
441,2013-08-19,益佰制药独立董事关于调整回购注销部分激励对象尚未解锁的限制性股票的独立意见,/disclosure/listedinfo/announcement/c/2013-08-18/600594_20130819_8.pdf
442,2013-08-19,益佰制药第五届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-18/600594_20130819_2.pdf
443,2013-08-19,益佰制药第五届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-18/600594_20130819_1.pdf
444,2013-08-19,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-18/600594_2013_zzy.pdf
445,2013-08-19,益佰制药半年报,/disclosure/listedinfo/announcement/c/2013-08-18/600594_2013_z.pdf
446,2013-09-17,益佰制药关于部分不符合激励条件的限制性股票回购注销完成公告,/disclosure/listedinfo/announcement/c/2013-09-16/600594_20130917_1.pdf
447,2013-10-29,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-28/600594_2013_3.pdf
448,2013-11-14,益佰制药关于收购百祥制药的补充公告,/disclosure/listedinfo/announcement/c/2013-11-13/600594_20131114_1.pdf
449,2013-11-22,益佰制药关于非公开发行股票申请获得中国证监会发审会审核通过的公告,/disclosure/listedinfo/announcement/c/2013-11-21/600594_20131122_1.pdf
450,2013-11-23,益佰制药关于调整非公开发行股票发行底价和发行数量的公告,/disclosure/listedinfo/announcement/c/2013-11-22/600594_20131123_1.pdf
451,2013-12-13,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2013-12-12/600594_20131213_2.pdf
452,2013-12-13,益佰制药关于非公开发行股票获得中国证监会核准批文的公告,/disclosure/listedinfo/announcement/c/2013-12-12/600594_20131213_3.pdf
453,2013-12-13,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2013-12-12/600594_20131213_1.pdf
454,2013-12-31,益佰制药关于股东股权质押公告,/disclosure/listedinfo/announcement/c/2013-12-30/600594_20131231_1.pdf
455,2014-01-21,益佰制药以募集资金置换预先投入的自筹资金公告,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_4.pdf
456,2014-01-21,益佰制药验资报告,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_11.pdf
457,2014-01-21,益佰制药签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_5.pdf
458,2014-01-21,益佰制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_3.pdf
459,2014-01-21,益佰制药公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_7.pdf
460,2014-01-21,益佰制药非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_6.pdf
461,2014-01-21,益佰制药非公开发行A股股票的发行情况报告书,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_12.pdf
462,2014-01-21,益佰制药独立董事关于以募集资金置换预先已投入募投项目自筹资金的独立意见,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_8.pdf
463,2014-01-21,益佰制药第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_2.pdf
464,2014-01-21,益佰制药第五届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_1.pdf
465,2014-01-21,益佰制药：关于贵州益佰制药股份有限公司自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_10.pdf
466,2014-01-21,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司使用非公开发行募集资金置换预先已投入募投项目自筹资金之专项核查意见,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_9.pdf
467,2014-01-21,益佰制药：北京市君致律师事务所关于贵州益佰制药股份有限公司非公开发行股票发行过程和发行对象合规性的见证法律意见书,/disclosure/listedinfo/announcement/c/2014-01-20/600594_20140121_13.pdf
468,2014-01-22,益佰制药关于聘任的会计师事务所名称变更公告,/disclosure/listedinfo/announcement/c/2014-01-21/600594_20140122_1.pdf
469,2014-02-13,益佰制药关于实际控制人、股东、关联方、收购人及本公司承诺履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-12/600594_20140213_1.pdf
470,2014-02-18,益佰制药监事会关于限制性股票第二个解锁期符合解锁条件事项的核查意见,/disclosure/listedinfo/announcement/c/2014-02-17/600594_20140218_8.pdf
471,2014-02-18,益佰制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2014-02-17/600594_20140218_4.pdf
472,2014-02-18,益佰制药股权激励计划限制性股票第二期解锁暨上市公告,/disclosure/listedinfo/announcement/c/2014-02-17/600594_20140218_3.pdf
473,2014-02-18,益佰制药公司章程（2014第二次修订）,/disclosure/listedinfo/announcement/c/2014-02-17/600594_20140218_6.pdf
474,2014-02-18,益佰制药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2014-02-17/600594_20140218_7.pdf
475,2014-02-18,益佰制药第五届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-02-17/600594_20140218_2.pdf
476,2014-02-18,益佰制药第五届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-02-17/600594_20140218_1.pdf
477,2014-02-18,益佰制药：北京市君致律师事务所关于贵州益佰制药股份有限公司A股限制性股票激励计划第二期限制性股票解锁事宜的法律意见书,/disclosure/listedinfo/announcement/c/2014-02-17/600594_20140218_5.pdf
478,2014-04-12,益佰制药关于转让黔德投资股权补充协议的公告,/disclosure/listedinfo/announcement/c/2014-04-11/600594_20140412_3.pdf
479,2014-04-12,益佰制药关于董事辞职公告,/disclosure/listedinfo/announcement/c/2014-04-11/600594_20140412_1.pdf
480,2014-04-12,益佰制药第五届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-11/600594_20140412_2.pdf
481,2014-04-19,益佰制药召开2013年度股东大会通知公告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_6.pdf
482,2014-04-19,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2014-04-18/600594_2013_nzy.pdf
483,2014-04-19,益佰制药年报,/disclosure/listedinfo/announcement/c/2014-04-18/600594_2013_n.pdf
484,2014-04-19,益佰制药内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_14.pdf
485,2014-04-19,益佰制药募集资金管理办法,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_17.pdf
486,2014-04-19,益佰制药关于使用银行承兑汇票支付募投项目资金的公告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_5.pdf
487,2014-04-19,益佰制药关于2014年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_4.pdf
488,2014-04-19,益佰制药关联交易决策制度,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_18.pdf
489,2014-04-19,益佰制药独立董事对公司2013年年度报告相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_21.pdf
490,2014-04-19,益佰制药独立董事对公司2013年年度报告相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_9.pdf
491,2014-04-19,益佰制药独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_12.pdf
492,2014-04-19,益佰制药董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_19.pdf
493,2014-04-19,益佰制药董事会审计委员会2013年度履职情况报告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_16.pdf
494,2014-04-19,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-18/600594_2014_1.pdf
495,2014-04-19,益佰制药第五届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_3.pdf
496,2014-04-19,益佰制药第五届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_2.pdf
497,2014-04-19,益佰制药：关于贵州益佰制药股份有限公司上市公司报告期控股股东及其他关联方资金占用情况表的说明,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_11.pdf
498,2014-04-19,益佰制药：关于贵州益佰制药股份有限公司2013年度净利润的鉴证报告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_20.pdf
499,2014-04-19,益佰制药2013年度审计报告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_10.pdf
500,2014-04-19,益佰制药2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-04-18/600594_20140419_13.pdf
501,2014-05-10,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2014-05-09/600594_20140510_1.pdf
502,2014-05-13,益佰制药2013年度现金分红说明会预告公告,/disclosure/listedinfo/announcement/c/2014-05-12/600594_20140513_1.pdf
503,2014-05-13,益佰制药2013年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-05-12/600594_20140513_2.pdf
504,2014-05-17,益佰制药关于召开2013年度股东大会提示性公告,/disclosure/listedinfo/announcement/c/2014-05-16/600594_20140517_2.pdf
505,2014-05-17,益佰制药参加贵州辖区上市公司2013年年度业绩网上说明会预告公告,/disclosure/listedinfo/announcement/c/2014-05-16/600594_20140517_1.pdf
506,2014-05-24,益佰制药2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-23/600594_20140524_1.pdf
507,2014-05-24,益佰制药2013年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2014-05-23/600594_20140524_2.pdf
508,2014-07-01,益佰制药重大事项停牌公告,/disclosure/listedinfo/announcement/c/2014-06-30/600594_20140701_1.pdf
509,2014-07-08,益佰制药重大事项复牌公告,/disclosure/listedinfo/announcement/c/2014-07-07/600594_20140708_6.pdf
510,2014-07-08,益佰制药关于收购天津中盛海天制药有限公司100%股权的公告,/disclosure/listedinfo/announcement/c/2014-07-07/600594_20140708_3.pdf
511,2014-07-08,益佰制药对全资子公司增资的公告,/disclosure/listedinfo/announcement/c/2014-07-07/600594_20140708_4.pdf
512,2014-07-08,益佰制药第五届监事会第七次会议决议,/disclosure/listedinfo/announcement/c/2014-07-07/600594_20140708_2.pdf
513,2014-07-08,益佰制药第五届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-07-07/600594_20140708_1.pdf
514,2014-07-08,益佰制药：天津中盛海天制药有限公司审计报告,/disclosure/listedinfo/announcement/c/2014-07-07/600594_20140708_7.pdf
515,2014-07-08,益佰制药2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-07-07/600594_20140708_5.pdf
516,2014-07-25,益佰制药募集资金临时补充流动资金公告,/disclosure/listedinfo/announcement/c/2014-07-24/600594_20140725_3.pdf
517,2014-07-25,益佰制药独立董事关于使用部分闲置募集资金临时补充流动资金的独立意见,/disclosure/listedinfo/announcement/c/2014-07-24/600594_20140725_4.pdf
518,2014-07-25,益佰制药第五届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-07-24/600594_20140725_2.pdf
519,2014-07-25,益佰制药第五届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2014-07-24/600594_20140725_1.pdf
520,2014-07-25,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司使用部分闲置募集资金临时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2014-07-24/600594_20140725_5.pdf
521,2014-08-16,益佰制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2014-08-15/600594_20140816_6.pdf
522,2014-08-16,益佰制药关于回购注销部分已不符合激励条件的原激励对象已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2014-08-15/600594_20140816_4.pdf
523,2014-08-16,益佰制药关于回购注销部分股权激励股份减少注册资本的债权人公告,/disclosure/listedinfo/announcement/c/2014-08-15/600594_20140816_5.pdf
524,2014-08-16,益佰制药公司章程（2014年第三次修订）,/disclosure/listedinfo/announcement/c/2014-08-15/600594_20140816_9.pdf
525,2014-08-16,益佰制药独立董事关于调整回购注销部分激励对象尚未解锁的限制性股票的独立意见,/disclosure/listedinfo/announcement/c/2014-08-15/600594_20140816_8.pdf
526,2014-08-16,益佰制药第五届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-15/600594_20140816_3.pdf
527,2014-08-16,益佰制药第五届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-15/600594_20140816_2.pdf
528,2014-08-16,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-15/600594_2014_zzy.pdf
529,2014-08-16,益佰制药半年报,/disclosure/listedinfo/announcement/c/2014-08-15/600594_2014_z.pdf
530,2014-10-13,益佰制药关于部分不符合激励条件的限制性股票回购注销完成公告,/disclosure/listedinfo/announcement/c/2014-10-12/600594_20141013_1.pdf
531,2014-10-31,益佰制药关于执行财政部2014年新颁布或修订会计准则的公告,/disclosure/listedinfo/announcement/c/2014-10-30/600594_20141031_3.pdf
532,2014-10-31,益佰制药关于收购海南长安国际制药有限公司部分股权的公告,/disclosure/listedinfo/announcement/c/2014-10-30/600594_20141031_4.pdf
533,2014-10-31,益佰制药独立董事关于公司执行2014年财政部新颁布或修订的相关会计准则的独立意见,/disclosure/listedinfo/announcement/c/2014-10-30/600594_20141031_6.pdf
534,2014-10-31,益佰制药第五届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-30/600594_20141031_2.pdf
535,2014-10-31,益佰制药第五届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-30/600594_20141031_1.pdf
536,2014-10-31,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-30/600594_2014_3.pdf
537,2014-10-31,益佰制药：海南长安国际制药有限公司审计报告,/disclosure/listedinfo/announcement/c/2014-10-30/600594_20141031_7.pdf
538,2015-01-06,益佰制药募集资金临时补充流动资金公告,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_3.pdf
539,2015-01-06,益佰制药关于推选职工监事的公告,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_4.pdf
540,2015-01-06,益佰制药关于监事辞职的公告,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_7.pdf
541,2015-01-06,益佰制药关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_8.pdf
542,2015-01-06,益佰制药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_5.pdf
543,2015-01-06,益佰制药关于董事会秘书辞职的公告,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_6.pdf
544,2015-01-06,益佰制药独立董事关于使用部分闲置募集资金临时补充流动资金的独立意见,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_10.pdf
545,2015-01-06,益佰制药独立董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_11.pdf
546,2015-01-06,益佰制药第五届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_2.pdf
547,2015-01-06,益佰制药第五届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_1.pdf
548,2015-01-06,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司使用部分闲置募集资金临时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2015-01-05/600594_20150106_9.pdf
549,2015-01-14,益佰制药非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2015-01-13/600594_20150114_1.pdf
550,2015-01-14,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司非公开发行限售股上市流通事项的核查意见,/disclosure/listedinfo/announcement/c/2015-01-13/600594_20150114_2.pdf
551,2015-01-21,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司非公开发行A股股票持续督导工作的现场检查工作报告,/disclosure/listedinfo/announcement/c/2015-01-20/600594_20150121_1.pdf
552,2015-01-30,益佰制药关于签订掌上药店“千县万店电商工程”战略合作协议的公告,/disclosure/listedinfo/announcement/c/2015-01-29/600594_20150130_1.pdf
553,2015-02-03,益佰制药监事会关于限制性股票第三个解锁期符合解锁条件事项的核查意见,/disclosure/listedinfo/announcement/c/2015-02-02/600594_20150203_6.pdf
554,2015-02-03,益佰制药股权激励计划限制性股票第三期解锁暨上市公告,/disclosure/listedinfo/announcement/c/2015-02-02/600594_20150203_3.pdf
555,2015-02-03,益佰制药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2015-02-02/600594_20150203_5.pdf
556,2015-02-03,益佰制药第五届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-02/600594_20150203_2.pdf
557,2015-02-03,益佰制药第五届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-02/600594_20150203_1.pdf
558,2015-02-03,益佰制药：北京市君致律师事务所关于贵州益佰制药股份有限公司A股限制性股票激励计划第三期限制性股票解锁事宜的法律意见书,/disclosure/listedinfo/announcement/c/2015-02-02/600594_20150203_4.pdf
559,2015-02-17,益佰制药员工持股计划（草案）摘要,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_3.pdf
560,2015-02-17,益佰制药员工持股计划（草案）,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_9.pdf
561,2015-02-17,益佰制药监事会关于员工持股计划相关事项的审核意见,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_7.pdf
562,2015-02-17,益佰制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_5.pdf
563,2015-02-17,益佰制药公司章程（2015第一次修订）,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_12.pdf
564,2015-02-17,益佰制药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_6.pdf
565,2015-02-17,益佰制药第五届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_2.pdf
566,2015-02-17,益佰制药第五届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_1.pdf
567,2015-02-17,益佰制药：北京市君致律师事务所关于贵州益佰制药股份有限公司员工持股计划的法律意见书,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_11.pdf
568,2015-02-17,益佰制药：[益佰制药员工持股计划1号资产管理计划]资产管理合同（适用于基金一对多托管业务）,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_8.pdf
569,2015-02-17,益佰制药：[益佰制药员工持股计划1号资产管理计划]资产管理合同（适用于基金一对多托管业务）,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_10.pdf
570,2015-02-17,益佰制药2015年第二次职工代表大会决议公告,/disclosure/listedinfo/announcement/c/2015-02-16/600594_20150217_4.pdf
571,2015-02-27,益佰制药2015年第一次临时股东大会通知,/disclosure/listedinfo/announcement/c/2015-02-26/600594_20150227_1.pdf
572,2015-03-03,益佰制药关于董事会秘书取得任职资格证书的公告,/disclosure/listedinfo/announcement/c/2015-03-02/600594_20150303_1.pdf
573,2015-03-06,益佰制药2015年第一次临时股东大会提示性公告,/disclosure/listedinfo/announcement/c/2015-03-05/600594_20150306_1.pdf
574,2015-03-06,益佰制药2015年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-03-05/600594_20150306_2.pdf
575,2015-03-17,益佰制药员工持股计划,/disclosure/listedinfo/announcement/c/2015-03-16/600594_20150317_3.pdf
576,2015-03-17,益佰制药2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-03-16/600594_20150317_1.pdf
577,2015-03-17,益佰制药2015年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-16/600594_20150317_2.pdf
578,2015-03-19,益佰制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2015-03-18/600594_20150319_3.pdf
579,2015-03-19,益佰制药关于拟作为主发起人设立民营银行的对外投资公告,/disclosure/listedinfo/announcement/c/2015-03-18/600594_20150319_2.pdf
580,2015-03-19,益佰制药公司章程（2015年第二次修订）,/disclosure/listedinfo/announcement/c/2015-03-18/600594_20150319_6.pdf
581,2015-03-19,益佰制药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2015-03-18/600594_20150319_5.pdf
582,2015-03-19,益佰制药董事会关于召开2015年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-03-18/600594_20150319_4.pdf
583,2015-03-19,益佰制药第五届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-18/600594_20150319_1.pdf
584,2015-03-31,益佰制药2015年第二次临时股东大会提示性公告,/disclosure/listedinfo/announcement/c/2015-03-30/600594_20150331_1.pdf
585,2015-03-31,益佰制药2015年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-03-30/600594_20150331_2.pdf
586,2015-04-11,益佰制药2015年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-04-10/600594_20150411_1.pdf
587,2015-04-11,益佰制药2015年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2015-04-10/600594_20150411_2.pdf
588,2015-04-29,益佰制药年报摘要,/disclosure/listedinfo/announcement/c/2015-04-28/600594_2014_nzy.pdf
589,2015-04-29,益佰制药年报,/disclosure/listedinfo/announcement/c/2015-04-28/600594_2014_n.pdf
590,2015-04-29,益佰制药募集资金存放与实际使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_13.pdf
591,2015-04-29,益佰制药关于会计估计变更的公告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_2.pdf
592,2015-04-29,益佰制药关于2014年年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_10.pdf
593,2015-04-29,益佰制药独立董事关于公司2014年年度报告相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_17.pdf
594,2015-04-29,益佰制药独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_7.pdf
595,2015-04-29,益佰制药董事会审计委员会2014年度履职情况报告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_9.pdf
596,2015-04-29,益佰制药第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-28/600594_2015_1.pdf
597,2015-04-29,益佰制药第五届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_1.pdf
598,2015-04-29,益佰制药第五届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_6.pdf
599,2015-04-29,益佰制药：关于公司上市公司报告期控股股东及其他关联方资金占用情况表的说明,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_11.pdf
600,2015-04-29,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司2014年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_14.pdf
601,2015-04-29,益佰制药2014年内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_12.pdf
602,2015-04-29,益佰制药2014年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_8.pdf
603,2015-04-29,益佰制药2014年度持续督导年度报告书,/disclosure/listedinfo/announcement/c/2015-04-28/600594_20150429_5.pdf
604,2015-04-30,益佰制药2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-04-29/600594_20150430_1.pdf
605,2015-05-01,益佰制药：关于贵州益佰制药股份有限公司会计政策和会计估计变更的专项说明,/disclosure/listedinfo/announcement/c/2015-04-30/600594_20150501_1.pdf
606,2015-05-01,益佰制药2015年员工持股计划首次持有人会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-30/600594_20150501_2.pdf
607,2015-05-13,益佰制药2014年度业绩网上说明会预告公告,/disclosure/listedinfo/announcement/c/2015-05-12/600594_20150513_1.pdf
608,2015-05-14,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2015-05-13/600594_20150514_1.pdf
609,2015-05-21,益佰制药关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-05-20/600594_20150521_1.pdf
610,2015-05-30,益佰制药关于银杏叶制剂产品自查情况的公告,/disclosure/listedinfo/announcement/c/2015-05-29/600594_20150530_1.pdf
611,2015-06-02,益佰制药2015年员工持股计划实施进展公告,/disclosure/listedinfo/announcement/c/2015-06-01/600594_20150602_1.pdf
612,2015-06-06,益佰制药2014年度现金分红说明会预告公告,/disclosure/listedinfo/announcement/c/2015-06-05/600594_20150606_1.pdf
613,2015-06-09,益佰制药2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-06-08/600594_20150609_1.pdf
614,2015-06-11,益佰制药2014年年度股东大会提示性公告,/disclosure/listedinfo/announcement/c/2015-06-10/600594_20150611_1.pdf
615,2015-06-20,益佰制药监事会关于变更部分募投项目投入事项的审核意见,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_8.pdf
616,2015-06-20,益佰制药关于召开2015年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_5.pdf
617,2015-06-20,益佰制药关于变更部分募投项目的公告,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_3.pdf
618,2015-06-20,益佰制药独立董事关于变更部分募投项目投入事项的独立意见,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_7.pdf
619,2015-06-20,益佰制药第五届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_2.pdf
620,2015-06-20,益佰制药第五届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_1.pdf
621,2015-06-20,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司变更部分募集资金投资项目之核查意见,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_6.pdf
622,2015-06-20,益佰制药2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_4.pdf
623,2015-06-20,益佰制药2014年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2015-06-19/600594_20150620_9.pdf
624,2015-06-27,益佰制药关于更换持续督导保荐代表人的公告,/disclosure/listedinfo/announcement/c/2015-06-26/600594_20150627_1.pdf
625,2015-06-30,益佰制药2015年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-06-29/600594_20150630_1.pdf
626,2015-07-01,益佰制药2015年员工持股计划完成股票购买公告,/disclosure/listedinfo/announcement/c/2015-06-30/600594_20150701_1.pdf
627,2015-07-01,益佰制药2015年第三次临时股东大会提示性公告,/disclosure/listedinfo/announcement/c/2015-06-30/600594_20150701_2.pdf
628,2015-07-07,益佰制药重大事项停牌公告,/disclosure/listedinfo/announcement/c/2015-07-06/600594_20150707_1.pdf
629,2015-07-09,益佰制药2015年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-07-08/600594_20150709_1.pdf
630,2015-07-09,益佰制药2015年第三次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2015-07-08/600594_20150709_2.pdf
631,2015-07-10,益佰制药关于参与贵州上市公司联合声明的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600594_20150710_2.pdf
632,2015-07-10,益佰制药2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-07-09/600594_20150710_1.pdf
633,2015-07-11,益佰制药重大事项复牌公告,/disclosure/listedinfo/announcement/c/2015-07-10/600594_20150711_2.pdf
634,2015-07-11,益佰制药关于投资设立肿瘤医疗产业并购基金的框架协议公告,/disclosure/listedinfo/announcement/c/2015-07-10/600594_20150711_3.pdf
635,2015-07-11,益佰制药关于实际控制人及公司高管计划增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-07-10/600594_20150711_1.pdf
636,2015-08-13,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2015-08-13/600594_20150813_1.pdf
637,2015-08-26,益佰制药半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-26/600594_2015_zzy.pdf
638,2015-08-26,益佰制药半年报,/disclosure/listedinfo/announcement/c/2015-08-26/600594_2015_z.pdf
639,2015-08-28,益佰制药关于高管增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-08-28/600594_20150828_1.pdf
640,2015-09-08,益佰制药关于在广州中医药大学金沙洲医院设立肿瘤中心《合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2015-09-08/600594_20150908_1.pdf
641,2015-09-12,益佰制药关于实际控制人及公司高管增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-09-12/600594_20150912_1.pdf
642,2015-10-10,益佰制药关于签订设立贵州百洋益佰肿瘤易复诊大数据有限公司合作协议的公告,/disclosure/listedinfo/announcement/c/2015-10-10/600594_20151010_1.pdf
643,2015-10-15,益佰制药关于签订设立上海益佰肿瘤医疗投资管理有限公司合作框架协议的公告,/disclosure/listedinfo/announcement/c/2015-10-15/600594_20151015_1.pdf
644,2015-10-24,益佰制药关于召开2015年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-10-24/600594_20151024_3.pdf
645,2015-10-24,益佰制药关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2015-10-24/600594_20151024_2.pdf
646,2015-10-24,益佰制药公司章程（2015年第三次修订）,/disclosure/listedinfo/announcement/c/2015-10-24/600594_20151024_5.pdf
647,2015-10-24,益佰制药第五届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-24/600594_20151024_1.pdf
648,2015-10-24,益佰制药第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-24/600594_2015_3.pdf
649,2015-10-31,益佰制药2015年第四次临时股东大会提示性公告,/disclosure/listedinfo/announcement/c/2015-10-31/600594_20151031_1.pdf
650,2015-11-03,益佰制药2015年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-11-03/600594_20151103_1.pdf
651,2015-11-11,益佰制药2015年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-11-11/600594_20151111_1.pdf
652,2015-11-11,益佰制药2015年第四次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2015-11-11/600594_20151111_2.pdf
653,2015-12-31,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2015-12-31/600594_20151231_1.pdf
654,2016-01-06,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2016-01-06/600594_20160106_1.pdf
655,2016-01-07,益佰制药关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2016-01-07/600594_20160107_1.pdf
656,2016-01-08,益佰制药关于撤回三个药品注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-08/600594_20160108_1.pdf
657,2016-01-09,益佰制药募集资金临时补充流动资金公告,/disclosure/listedinfo/announcement/c/2016-01-09/600594_20160109_3.pdf
658,2016-01-09,益佰制药独立董事关于使用部分闲置募集资金临时补充流动资金的独立意见,/disclosure/listedinfo/announcement/c/2016-01-09/600594_20160109_4.pdf
659,2016-01-09,益佰制药第五届监事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2016-01-09/600594_20160109_2.pdf
660,2016-01-09,益佰制药第五届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-01-09/600594_20160109_1.pdf
661,2016-01-09,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司使用部分闲置募集资金临时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2016-01-09/600594_20160109_5.pdf
662,2016-01-15,益佰制药2015年年度业绩预减公告,/disclosure/listedinfo/announcement/c/2016-01-15/600594_20160115_1.pdf
663,2016-01-16,益佰制药关于收购淮南朝阳医院管理有限公司32.5%股权并增资扩股至53%股权的公告,/disclosure/listedinfo/announcement/c/2016-01-16/600594_20160116_2.pdf
664,2016-01-16,益佰制药第五届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-01-16/600594_20160116_1.pdf
665,2016-01-20,益佰制药：淮南朝阳医院审计报告,/disclosure/listedinfo/announcement/c/2016-01-20/600594_20160120_1.pdf
666,2016-01-20,益佰制药：淮南朝阳医院管理有限公司审计报告,/disclosure/listedinfo/announcement/c/2016-01-20/600594_20160120_2.pdf
667,2016-01-27,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2016-01-27/600594_20160127_1.pdf
668,2016-01-28,益佰制药关于变更保荐代表人的公告,/disclosure/listedinfo/announcement/c/2016-01-28/600594_20160128_1.pdf
669,2016-04-15,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司非公开发行A股股票持续督导工作的现场检查工作报告,/disclosure/listedinfo/announcement/c/2016-04-15/600594_20160415_1.pdf
670,2016-04-26,益佰制药关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2016-04-26/600594_20160426_2.pdf
671,2016-04-26,益佰制药复牌提示性公告,/disclosure/listedinfo/announcement/c/2016-04-26/600594_20160426_1.pdf
672,2016-04-28,益佰制药审计报告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_7.pdf
673,2016-04-28,益佰制药募集资金存放与实际使用情况的鉴证报筲,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_12.pdf
674,2016-04-28,益佰制药关于2015年年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_11.pdf
675,2016-04-28,益佰制药独立董事关于公司2015年年度报告相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_16.pdf
676,2016-04-28,益佰制药独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_9.pdf
677,2016-04-28,益佰制药董事会审计委员会2015年度履职情况报告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_15.pdf
678,2016-04-28,益佰制药第五届监事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_2.pdf
679,2016-04-28,益佰制药第五届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_1.pdf
680,2016-04-28,益佰制药：关于贵州益佰制药股份有限公司上市公司报告期控股股东及其他关联方资金占用情况表的说明,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_8.pdf
681,2016-04-28,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司2015年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_14.pdf
682,2016-04-28,益佰制药2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_2016_1.pdf
683,2016-04-28,益佰制药2015年年度报告摘要,/disclosure/listedinfo/announcement/c/2016-04-28/600594_2015_nzy.pdf
684,2016-04-28,益佰制药2015年年度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_2015_n.pdf
685,2016-04-28,益佰制药2015年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_13.pdf
686,2016-04-28,益佰制药2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_10.pdf
687,2016-04-28,益佰制药2015年度持续督导年度报告书,/disclosure/listedinfo/announcement/c/2016-04-28/600594_20160428_5.pdf
688,2016-05-11,益佰制药关于益佰艾康肿瘤医生集团完成工商注册的公告,/disclosure/listedinfo/announcement/c/2016-05-11/600594_20160511_1.pdf
689,2016-05-12,益佰制药关于益佰艾康肿瘤医生集团完成工商注册的补充更正公告,/disclosure/listedinfo/announcement/c/2016-05-12/600594_20160512_1.pdf
690,2016-05-13,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司非公开发行股票之持续督导保荐总结报告书,/disclosure/listedinfo/announcement/c/2016-05-13/600594_20160513_1.pdf
691,2016-05-19,益佰制药关于设立哈尔滨益佰医疗投资有限责任公司的公告,/disclosure/listedinfo/announcement/c/2016-05-19/600594_20160519_1.pdf
692,2016-05-25,益佰制药银行间债券市场非金融企业债务融资工具信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2016-05-25/600594_20160525_6.pdf
693,2016-05-25,益佰制药关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-05-25/600594_20160525_4.pdf
694,2016-05-25,益佰制药公开发行公司债券发行预案公告,/disclosure/listedinfo/announcement/c/2016-05-25/600594_20160525_3.pdf
695,2016-05-25,益佰制药第五届监事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-25/600594_20160525_2.pdf
696,2016-05-25,益佰制药第五届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-25/600594_20160525_1.pdf
697,2016-05-25,益佰制药2015年度现金分红说明会预告公告,/disclosure/listedinfo/announcement/c/2016-05-25/600594_20160525_5.pdf
698,2016-06-01,益佰制药关于签署投资毕节市肿瘤医院有限公司合作协议的公告,/disclosure/listedinfo/announcement/c/2016-06-01/600594_20160601_1.pdf
699,2016-06-02,益佰制药2015年度网上业绩说明会预告公告,/disclosure/listedinfo/announcement/c/2016-06-02/600594_20160602_1.pdf
700,2016-06-04,益佰制药2015年年度股东大会提示性公告,/disclosure/listedinfo/announcement/c/2016-06-04/600594_20160604_2.pdf
701,2016-06-04,益佰制药2015年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-06-04/600594_20160604_1.pdf
702,2016-06-14,益佰制药关于投资设立安徽益佰肿瘤医疗投资有限公司的公告,/disclosure/listedinfo/announcement/c/2016-06-14/600594_20160614_1.pdf
703,2016-06-14,益佰制药关于投资设立安徽益佰艾康肿瘤医生集团医疗有限公司的公告,/disclosure/listedinfo/announcement/c/2016-06-14/600594_20160614_2.pdf
704,2016-06-15,益佰制药2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-06-15/600594_20160615_1.pdf
705,2016-06-15,益佰制药2015年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2016-06-15/600594_20160615_2.pdf
706,2016-06-17,益佰制药关于投资设立杭州益翰投资管理有限公司的公告,/disclosure/listedinfo/announcement/c/2016-06-17/600594_20160617_1.pdf
707,2016-06-21,益佰制药关于投资设立杭州益翰投资管理有限公司的补充公告,/disclosure/listedinfo/announcement/c/2016-06-21/600594_20160621_1.pdf
708,2016-06-25,益佰制药关于与澳洲ICON拟合资设立上海益佰艾康肿瘤医疗管理公司初步合作协议的公告,/disclosure/listedinfo/announcement/c/2016-06-25/600594_20160625_1.pdf
709,2016-07-14,益佰制药关于向康德乐（中国）出售益佰医药75%股权的公告,/disclosure/listedinfo/announcement/c/2016-07-14/600594_20160714_1.pdf
710,2016-07-20,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2016-07-20/600594_20160720_2.pdf
711,2016-07-20,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2016-07-20/600594_20160720_1.pdf
712,2016-07-22,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2016-07-22/600594_20160722_3.pdf
713,2016-07-22,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2016-07-22/600594_20160722_2.pdf
714,2016-07-22,益佰制药2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-07-22/600594_20160722_1.pdf
715,2016-07-26,益佰制药关于发起设立民营银行事项进展的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-26/600594_20160726_1.pdf
716,2016-08-19,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2016-08-19/600594_20160819_2.pdf
717,2016-08-19,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2016-08-19/600594_20160819_1.pdf
718,2016-08-20,益佰制药关于收到中国证监会贵州监管局监管关注函的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600594_20160820_1.pdf
719,2016-08-23,益佰制药关于子公司取得GMP证书的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-23/600594_20160823_1.pdf
720,2016-08-23,益佰制药关于与淮南市人民政府签署战略合作协议的公告,/disclosure/listedinfo/announcement/c/2016-08-23/600594_20160823_2.pdf
721,2016-08-27,益佰制药关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-08-27/600594_20160827_4.pdf
722,2016-08-27,益佰制药关于推选职工监事的公告,/disclosure/listedinfo/announcement/c/2016-08-27/600594_20160827_3.pdf
723,2016-08-27,益佰制药关于董事会换届选举的独立意见,/disclosure/listedinfo/announcement/c/2016-08-27/600594_20160827_6.pdf
724,2016-08-27,益佰制药独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-08-27/600594_20160827_7.pdf
725,2016-08-27,益佰制药独立董事候选人声明（王新华）,/disclosure/listedinfo/announcement/c/2016-08-27/600594_20160827_9.pdf
726,2016-08-27,益佰制药独立董事候选人声明（彭文宗、邓海根）,/disclosure/listedinfo/announcement/c/2016-08-27/600594_20160827_8.pdf
727,2016-08-27,益佰制药第五届监事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/600594_20160827_2.pdf
728,2016-08-27,益佰制药第五届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/600594_20160827_1.pdf
729,2016-08-27,益佰制药2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-27/600594_2016_zzy.pdf
730,2016-08-27,益佰制药2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-27/600594_2016_z.pdf
731,2016-08-30,益佰制药：高盛高华证券有限责任公司关于中国证券监督管理委员会贵州监管局《关于贵州益佰制药股份有限公司的监管关注函》之核查意见,/disclosure/listedinfo/announcement/c/2016-08-30/600594_20160830_1.pdf
732,2016-09-02,益佰制药2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-09-02/600594_20160902_1.pdf
733,2016-09-05,益佰制药关于召开2016年第一次临时股东大会提示性公告,/disclosure/listedinfo/announcement/c/2016-09-05/600594_20160905_1.pdf
734,2016-09-13,益佰制药独立董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2016-09-13/600594_20160913_5.pdf
735,2016-09-13,益佰制药第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-09-13/600594_20160913_3.pdf
736,2016-09-13,益佰制药第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-09-13/600594_20160913_2.pdf
737,2016-09-13,益佰制药2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-09-13/600594_20160913_1.pdf
738,2016-09-13,益佰制药2016年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2016-09-13/600594_20160913_4.pdf
739,2016-09-15,益佰制药关于投资设立天津益佰艾康医疗科技有限公司的公告,/disclosure/listedinfo/announcement/c/2016-09-15/600594_20160915_1.pdf
740,2016-09-28,益佰制药关于投资设立湖南益佰艾康肿瘤医生集团医疗有限公司的公告,/disclosure/listedinfo/announcement/c/2016-09-28/600594_20160928_1.pdf
741,2016-10-29,益佰制药2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-29/600594_2016_3.pdf
742,2016-11-05,益佰制药关于子公司对四川翰博瑞得肿瘤医疗科技有限公司增资的公告,/disclosure/listedinfo/announcement/c/2016-11-05/600594_20161105_2.pdf
743,2016-11-05,益佰制药关于对南京市睿科投资管理有限公司增资的公告,/disclosure/listedinfo/announcement/c/2016-11-05/600594_20161105_1.pdf
744,2016-11-15,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2016-11-15/600594_20161115_2.pdf
745,2016-11-15,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2016-11-15/600594_20161115_1.pdf
746,2016-11-23,益佰制药关于股东股权质押解除公告,/disclosure/listedinfo/announcement/c/2016-11-23/600594_20161123_2.pdf
747,2016-11-23,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2016-11-23/600594_20161123_1.pdf
748,2016-11-26,益佰制药关于投资设立辽宁益佰艾康肿瘤医生联盟医疗有限公司的公告,/disclosure/listedinfo/announcement/c/2016-11-26/600594_20161126_1.pdf
749,2016-11-26,益佰制药关于高管辞职的公告,/disclosure/listedinfo/announcement/c/2016-11-26/600594_20161126_2.pdf
750,2016-11-30,益佰制药关于公司债发行申请获得中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2016-11-30/600594_20161130_1.pdf
751,2016-12-01,益佰制药关于收购上海华謇医疗投资管理股份有限公司9.06%股权并增资扩股至53.63%股权的公告,/disclosure/listedinfo/announcement/c/2016-12-01/600594_20161201_1.pdf
752,2016-12-02,益佰制药更正公告,/disclosure/listedinfo/announcement/c/2016-12-02/600594_20161202_1.pdf
753,2017-01-05,益佰制药关于子公司取得肿瘤医疗机构设置批准书的提示性公告,/disclosure/listedinfo/announcement/c/2017-01-05/600594_20170105_1.pdf
754,2017-01-07,益佰制药关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2017-01-07/600594_20170107_1.pdf
755,2017-01-10,益佰制药募集资金临时补充流动资金公告,/disclosure/listedinfo/announcement/c/2017-01-10/600594_20170110_3.pdf
756,2017-01-10,益佰制药独立董事关于使用部分闲置募集资金临时补充流动资金的独立意见,/disclosure/listedinfo/announcement/c/2017-01-10/600594_20170110_5.pdf
757,2017-01-10,益佰制药第六届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-10/600594_20170110_2.pdf
758,2017-01-10,益佰制药第六届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-10/600594_20170110_1.pdf
759,2017-01-10,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司使用部分闲置募集资金临时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2017-01-10/600594_20170110_4.pdf
760,2017-01-12,益佰制药非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2017-01-12/600594_20170112_1.pdf
761,2017-01-12,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司非公开发行限售股上市流通事项的核查意见,/disclosure/listedinfo/announcement/c/2017-01-12/600594_20170112_2.pdf
762,2017-01-26,益佰制药2016年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-01-26/600594_20170126_1.pdf
763,2017-02-04,益佰制药高管增持公告,/disclosure/listedinfo/announcement/c/2017-02-04/600594_20170204_1.pdf
764,2017-02-10,益佰制药关于与泉州滨海医院签署项目合作协议的公告,/disclosure/listedinfo/announcement/c/2017-02-10/600594_20170210_1.pdf
765,2017-02-21,益佰制药关于收购绵阳富临医院90%股权的公告,/disclosure/listedinfo/announcement/c/2017-02-21/600594_20170221_1.pdf
766,2017-02-23,益佰制药关于收到上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2017-02-23/600594_20170223_1.pdf
767,2017-02-25,益佰制药关于投资设立福建益佰艾康肿瘤医生集团医疗有限公司的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600594_20170225_2.pdf
768,2017-02-25,益佰制药关于产品进入2017年版国家医保目录的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600594_20170225_1.pdf
769,2017-02-28,益佰制药关于收购医疗资产事项问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-02-28/600594_20170228_1.pdf
770,2017-03-01,益佰制药关于产品进入2017年版国家医保目录的补充公告,/disclosure/listedinfo/announcement/c/2017-03-01/600594_20170301_1.pdf
771,2017-03-03,益佰制药关于员工持股计划出售完毕暨终止的公告,/disclosure/listedinfo/announcement/c/2017-03-03/600594_20170303_1.pdf
772,2017-03-03,益佰制药关于部分董事、监事、高管及其他核心管理人员增持公司股份的公告,/disclosure/listedinfo/announcement/c/2017-03-03/600594_20170303_2.pdf
773,2017-04-19,益佰制药关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2017-04-19/600594_20170419_1.pdf
774,2017-04-27,益佰制药关于预计2017年度日常关联交易的公告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_3.pdf
775,2017-04-27,益佰制药关于2016年年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_12.pdf
776,2017-04-27,益佰制药独立董事关于公司2016年年度报告相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_6.pdf
777,2017-04-27,益佰制药独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_10.pdf
778,2017-04-27,益佰制药董事会审计委员会2016年度履职情况报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_16.pdf
779,2017-04-27,益佰制药第六届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_2.pdf
780,2017-04-27,益佰制药第六届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_1.pdf
781,2017-04-27,益佰制药：募集资金存放与实际使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_13.pdf
782,2017-04-27,益佰制药：关于贵州益佰制药股份有限公司上市公司报告期控股股东及其他关联方资金占用情况表的说明,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_9.pdf
783,2017-04-27,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司2016年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_15.pdf
784,2017-04-27,益佰制药：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_8.pdf
785,2017-04-27,益佰制药：2016年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_14.pdf
786,2017-04-27,益佰制药2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_2017_1.pdf
787,2017-04-27,益佰制药2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-04-27/600594_2016_nzy.pdf
788,2017-04-27,益佰制药2016年年度报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_2016_n.pdf
789,2017-04-27,益佰制药2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-04-27/600594_20170427_11.pdf
790,2017-05-05,益佰制药关于预计2017年度日常关联交易的补充更正公告,/disclosure/listedinfo/announcement/c/2017-05-05/600594_20170505_1.pdf
791,2017-05-20,益佰制药关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-20/600594_20170520_1.pdf
792,2017-06-02,益佰制药2016年度现金分红说明会预告公告,/disclosure/listedinfo/announcement/c/2017-06-02/600594_20170602_1.pdf
793,2017-06-06,益佰制药2016年年度股东大会提示性公告,/disclosure/listedinfo/announcement/c/2017-06-06/600594_20170606_1.pdf
794,2017-06-06,益佰制药2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-06-06/600594_20170606_2.pdf
795,2017-06-16,益佰制药2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-16/600594_20170616_1.pdf
796,2017-06-16,益佰制药2016年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-06-16/600594_20170616_2.pdf
797,2017-06-20,益佰制药关于受让辽阳市曼迪科医疗企业管理服务有限公司15%股权并增资扩股至59%股权的公告,/disclosure/listedinfo/announcement/c/2017-06-20/600594_20170620_1.pdf
798,2017-07-12,益佰制药2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-07-12/600594_20170712_1.pdf
799,2017-07-22,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2017-07-22/600594_20170722_2.pdf
800,2017-07-22,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2017-07-22/600594_20170722_1.pdf
801,2017-08-18,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2017-08-18/600594_20170818_2.pdf
802,2017-08-18,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2017-08-18/600594_20170818_1.pdf
803,2017-08-19,益佰制药2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-19/600594_2017_zzy.pdf
804,2017-08-19,益佰制药2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-19/600594_2017_z.pdf
805,2017-08-23,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2017-08-23/600594_20170823_1.pdf
806,2017-09-01,益佰制药关于医保目录限用的澄清公告,/disclosure/listedinfo/announcement/c/2017-09-01/600594_20170901_1.pdf
807,2017-09-20,益佰制药关于2017年半年度报告事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2017-09-20/600594_20170920_1.pdf
808,2017-09-26,益佰制药关于申请延期回复2017年半年度报告事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2017-09-26/600594_20170926_1.pdf
809,2017-09-29,益佰制药关于申请延期回复2017年半年度报告事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2017-09-29/600594_20170929_1.pdf
810,2017-10-10,益佰制药关于2017年半年度报告事后审核问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-10-10/600594_20171010_1.pdf
811,2017-10-11,益佰制药拟对合并天津中盛海天制药有限公司形成的商誉进行减值测试项目资产评估报告书（同致信德评报字（2016）第077号）,/disclosure/listedinfo/announcement/c/2017-10-11/600594_20171011_8.pdf
812,2017-10-11,益佰制药拟对合并海南长安国际制药有限公司形成的商誉进行减值测试项目资产评估报告（鄂中联评报字（2015）第014号）,/disclosure/listedinfo/announcement/c/2017-10-11/600594_20171011_7.pdf
813,2017-10-11,益佰制药股权收购涉及的淮南朝阳医院管理有限公司评估项目资产评估报告书（同致信德评报字（2017）第0088号）,/disclosure/listedinfo/announcement/c/2017-10-11/600594_20171011_6.pdf
814,2017-10-11,益佰制药：拟对合并贵州益佰女子大药厂有限责任公司形成的商誉进行减值测试项目资产评估报告书（同致信德评报字（2016）第076号）,/disclosure/listedinfo/announcement/c/2017-10-11/600594_20171011_5.pdf
815,2017-10-11,益佰制药：贵州苗医药实业有限公司拟对合并贵州益佰女子大药厂有限责任公司形成的商誉进行减值测试项目资产评估报告（鄂中联评报字（2015）第015号）,/disclosure/listedinfo/announcement/c/2017-10-11/600594_20171011_4.pdf
816,2017-10-11,益佰制药：北京中证天通会计师事务所（特殊普通合伙）对上交所《关于对贵州益佰制药股份有限公司2017年半年度报告的事后审核问询函》回复的说明,/disclosure/listedinfo/announcement/c/2017-10-11/600594_20171011_3.pdf
817,2017-10-11,益佰制药2017年半年度报告更正公告,/disclosure/listedinfo/announcement/c/2017-10-11/600594_20171011_1.pdf
818,2017-10-11,益佰制药2017年半年度报告（修订版）,/disclosure/listedinfo/announcement/c/2017-10-11/600594_2017_z.pdf
819,2017-10-18,益佰制药公开发行2017年公司债券（第一期）信用评级报告,/disclosure/listedinfo/announcement/c/2017-10-18/600594_20171018_4.pdf
820,2017-10-18,益佰制药公开发行2017年公司债券（第一期）募集说明书摘要（面向合格投资者）,/disclosure/listedinfo/announcement/c/2017-10-18/600594_20171018_3.pdf
821,2017-10-18,益佰制药公开发行2017年公司债券（第一期）募集说明书（面向合格投资者）,/disclosure/listedinfo/announcement/c/2017-10-18/600594_20171018_1.pdf
822,2017-10-18,益佰制药公开发行2017年公司债券（第一期）发行公告（面向合格投资者）,/disclosure/listedinfo/announcement/c/2017-10-18/600594_20171018_2.pdf
823,2017-10-19,益佰制药：关于延长贵州益佰制药股份有限公司公开发行2017年公司债券（第一期）簿记建档时间的公告,/disclosure/listedinfo/announcement/c/2017-10-19/600594_20171019_1.pdf
824,2017-10-20,益佰制药公开发行2017年公司债券（第一期）票面利率公告,/disclosure/listedinfo/announcement/c/2017-10-20/600594_20171020_1.pdf
825,2017-10-24,益佰制药公开发行2017年公司债券（第一期）发行结果公告,/disclosure/listedinfo/announcement/c/2017-10-24/600594_20171024_1.pdf
826,2017-10-28,益佰制药2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-28/600594_2017_3.pdf
827,2017-11-02,益佰制药公开发行2017年公司债券（第一期）在上海证券交易所上市的公告,/disclosure/listedinfo/announcement/c/2017-11-02/600594_20171102_1.pdf
828,2017-11-11,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2017-11-11/600594_20171111_1.pdf
829,2017-11-23,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2017-11-23/600594_20171123_2.pdf
830,2017-11-23,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2017-11-23/600594_20171123_1.pdf
831,2017-11-29,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2017-11-29/600594_20171129_1.pdf
832,2017-12-01,益佰制药关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-12-01/600594_20171201_4.pdf
833,2017-12-01,益佰制药关于以集中竞价交易方式回购股份预案公告,/disclosure/listedinfo/announcement/c/2017-12-01/600594_20171201_3.pdf
834,2017-12-01,益佰制药独立董事关于公司以集中竞价交易方式回购股份的独立意见,/disclosure/listedinfo/announcement/c/2017-12-01/600594_20171201_2.pdf
835,2017-12-01,益佰制药第六届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-01/600594_20171201_1.pdf
836,2017-12-02,益佰制药关于股东股份解除质押的公告,/disclosure/listedinfo/announcement/c/2017-12-02/600594_20171202_1.pdf
837,2017-12-05,益佰制药关于2017年第一次临时股东大会更正补充公告,/disclosure/listedinfo/announcement/c/2017-12-05/600594_20171205_1.pdf
838,2017-12-07,益佰制药：关于召开贵州益佰制药股份有限公司2017年第一次“17益佰01”债券持有人会议的通知,/disclosure/listedinfo/announcement/c/2017-12-07/600594_20171207_1.pdf
839,2017-12-12,益佰制药关于股东股份解除质押的公告,/disclosure/listedinfo/announcement/c/2017-12-12/600594_20171212_1.pdf
840,2017-12-13,益佰制药关于召开2017年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-13/600594_20171213_1.pdf
841,2017-12-13,益佰制药关于前十名无限售条件股东情况的公告,/disclosure/listedinfo/announcement/c/2017-12-13/600594_20171213_2.pdf
842,2017-12-13,益佰制药：国泰君安证券股份有限公司关于贵州益佰制药股份有限公司回购部分社会公众股份之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2017-12-13/600594_20171213_3.pdf
843,2017-12-13,益佰制药2017年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-12-13/600594_20171213_4.pdf
844,2017-12-19,益佰制药关于通知债权人的公告,/disclosure/listedinfo/announcement/c/2017-12-19/600594_20171219_3.pdf
845,2017-12-19,益佰制药2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-12-19/600594_20171219_1.pdf
846,2017-12-19,益佰制药2017年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-12-19/600594_20171219_2.pdf
847,2017-12-21,益佰制药关于终止实施回购股份的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600594_20171221_3.pdf
848,2017-12-21,益佰制药关于2017年第一次“17益佰01”债券持有人会议决议的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600594_20171221_1.pdf
849,2017-12-21,益佰制药：北京市君致律师事务所关于贵州益佰制药股份有限公司2017年公司债券（第一期）2017年第一次债券持有人会议法律意见书,/disclosure/listedinfo/announcement/c/2017-12-21/600594_20171221_2.pdf
850,2017-12-23,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2017-12-23/600594_20171223_1.pdf
851,2017-12-23,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2017-12-23/600594_20171223_2.pdf
852,2017-12-27,益佰制药关于签署收购富临医院90%股权补充协议的公告,/disclosure/listedinfo/announcement/c/2017-12-27/600594_20171227_2.pdf
853,2017-12-27,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2017-12-27/600594_20171227_1.pdf
854,2017-12-27,益佰制药：绵阳富临医院有限公司审计报告,/disclosure/listedinfo/announcement/c/2017-12-27/600594_20171227_3.pdf
855,2017-12-29,益佰制药关于胃蛋白酶颗粒药品抽检不合格情况的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600594_20171229_1.pdf
856,2017-12-30,益佰制药股票质押式回购交易延期购回公告,/disclosure/listedinfo/announcement/c/2017-12-30/600594_20171230_1.pdf
857,2018-01-06,益佰制药关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2018-01-06/600594_20180106_1.pdf
858,2018-01-09,益佰制药募集资金临时补充流动资金公告,/disclosure/listedinfo/announcement/c/2018-01-09/600594_20180109_3.pdf
859,2018-01-09,益佰制药独立董事关于使用部分闲置募集资金临时补充流动资金的独立意见,/disclosure/listedinfo/announcement/c/2018-01-09/600594_20180109_4.pdf
860,2018-01-09,益佰制药第六届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2018-01-09/600594_20180109_2.pdf
861,2018-01-09,益佰制药第六届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2018-01-09/600594_20180109_1.pdf
862,2018-01-09,益佰制药：高盛高华证券有限责任公司关于贵州益佰制药股份有限公司使用部分闲置募集资金临时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2018-01-09/600594_20180109_5.pdf
863,2018-02-07,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2018-02-07/600594_20180207_1.pdf
864,2018-02-10,益佰制药股票质押式回购交易公告,/disclosure/listedinfo/announcement/c/2018-02-10/600594_20180210_1.pdf
